Kısa etkili inhale beta 2 mimetik bir ilaç olan salbutamol, bronkospazm ve solunum sıkıntısı durumlarında çok sık kullanılmaktadır ama ülkemizde intihar amaçlı alımı nadir görülen bir durumdur. Salbutamole bağlı komplikasyonlar iyi bilinmektedir ve terapotik dozlarda da ortaya çıkabilir. İlaca bağlı toksikasyon geliştiğinde hiperaktivite, tremor, konvülzyon, hiperglisemi, hipokalemi, hipomagnezemi, laktik asidoz, hipotansiyon, hipertansiyon, konjestif kalp yetmezliği, miyokard iskemisi, atriyal ve ventriküler ektopik atımlar, atriyal aritmiler, QT uzaması ve ventriküler taşikardi gibi aritmiler ile ani kardiyak ölüm ortaya çıkabilir. Bu makalede, intihar amaçlı olarak salbutamolün tablet formundan 200 mgr kullanan 15 yaşındaki bir hasta sunuldu ve literatür bilgileri eşliğinde çocuklarda salbutamol zehirlenmesine yaklaşım tartışıldı.
Salbutamol, a drug with short-acting inhaled beta 2 mimetic effect, is very frequently used in cases of bronchospasm and respiratory distress; however, its intake for suicide purposes is rare in Turkey. Salbutamol-induced complications are well established and may be seen at therapeutic doses. When drug-related intoxication develops, hyperactivity, tremor, convulsion, hyperglycemia, hypokalemia, hypomagnesemia, lactic acidosis, hypotension, hypertension, congestive heart failure, myocardial ischemia, atrial and ventricular ectopic heart beats, atrial arrhythmias, QT prolongation and arrhythmias such as ventricular tachycardia and sudden cardiac death may occur. This paper presents a 15-year-old patient who used 200 mg salbutamol in tablet form for suicide purposes and discusses the approach to salbutamol intoxication with a review of the literature information
Other ID | JA64GB79DU |
---|---|
Journal Section | Case Report |
Authors | |
Publication Date | June 1, 2017 |
Submission Date | June 1, 2017 |
Published in Issue | Year 2017 Volume: 11 Issue: 2 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.